VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-76 Cr | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr | ₹56 Cr |
What is the latest Cash Flow from Investing Activities ratio of VENUS REMEDIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-76 Cr |
Mar2024 | ₹-7.21 Cr |
Mar2023 | ₹-51 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹56 Cr |
How is Cash Flow from Investing Activities of VENUS REMEDIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-76 Cr | Negative | |
Mar2024 | ₹-7.21 Cr | Negative | |
Mar2023 | ₹-51 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹56 Cr | - |
Compare Cash Flow from Investing Activities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹617.5 Cr | 2.7% | 2% | 36.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | -0.3% | 3.2% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,458.0 Cr | 7.2% | 8.6% | 6.8% | Stock Analytics | |
CIPLA | ₹125,842.0 Cr | 3% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,547.0 Cr | -0.5% | NA | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,866.0 Cr | -1.1% | -5.3% | -6.3% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 2.7% |
2% |
36.8% |
SENSEX | 1% |
0.9% |
1.2% |
You may also like the below Video Courses